nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCC1—Etoposide—brain cancer	0.154	0.212	CbGbCtD
Mifepristone—CYP2D6—Lomustine—brain cancer	0.145	0.2	CbGbCtD
Mifepristone—CYP2D6—Hydroxyurea—brain cancer	0.11	0.151	CbGbCtD
Mifepristone—CYP3A4—Temozolomide—brain cancer	0.108	0.149	CbGbCtD
Mifepristone—CYP3A4—Lomustine—brain cancer	0.0919	0.127	CbGbCtD
Mifepristone—CYP3A5—Etoposide—brain cancer	0.057	0.0787	CbGbCtD
Mifepristone—ABCB1—Etoposide—brain cancer	0.0371	0.0512	CbGbCtD
Mifepristone—CYP3A4—Etoposide—brain cancer	0.0222	0.0307	CbGbCtD
Mifepristone—Vaginal haemorrhage—Temozolomide—brain cancer	0.00257	0.0141	CcSEcCtD
Mifepristone—Haemoglobin—Lomustine—brain cancer	0.0025	0.0137	CcSEcCtD
Mifepristone—Haemorrhage—Lomustine—brain cancer	0.00249	0.0137	CcSEcCtD
Mifepristone—Rash maculo-papular—Hydroxyurea—brain cancer	0.00222	0.0122	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00206	0.0113	CcSEcCtD
Mifepristone—Infection—Carboplatin—brain cancer	0.00201	0.011	CcSEcCtD
Mifepristone—Infection—Lomustine—brain cancer	0.00176	0.00965	CcSEcCtD
Mifepristone—Pain—Carboplatin—brain cancer	0.00173	0.0095	CcSEcCtD
Mifepristone—Anorexia—Lomustine—brain cancer	0.00169	0.00926	CcSEcCtD
Mifepristone—Body temperature increased—Carboplatin—brain cancer	0.0016	0.00878	CcSEcCtD
Mifepristone—Breast disorder—Hydroxyurea—brain cancer	0.0016	0.00878	CcSEcCtD
Mifepristone—Haemoglobin—Procarbazine—brain cancer	0.00159	0.00873	CcSEcCtD
Mifepristone—Haemorrhage—Procarbazine—brain cancer	0.00158	0.00868	CcSEcCtD
Mifepristone—Decreased appetite—Lomustine—brain cancer	0.00154	0.00845	CcSEcCtD
Mifepristone—PGR—blood vessel—brain cancer	0.00152	0.0725	CbGeAlD
Mifepristone—Hot flush—Temozolomide—brain cancer	0.00148	0.00811	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Temozolomide—brain cancer	0.00146	0.00804	CcSEcCtD
Mifepristone—Menopausal symptoms—Temozolomide—brain cancer	0.00146	0.00804	CcSEcCtD
Mifepristone—Thirst—Temozolomide—brain cancer	0.00145	0.00798	CcSEcCtD
Mifepristone—PGR—hindbrain—brain cancer	0.00145	0.0692	CbGeAlD
Mifepristone—Chills—Procarbazine—brain cancer	0.00142	0.00779	CcSEcCtD
Mifepristone—Body temperature increased—Lomustine—brain cancer	0.0014	0.00768	CcSEcCtD
Mifepristone—Rash maculo-papular—Etoposide—brain cancer	0.00138	0.0076	CcSEcCtD
Mifepristone—Infestation NOS—Hydroxyurea—brain cancer	0.00136	0.00749	CcSEcCtD
Mifepristone—Infestation—Hydroxyurea—brain cancer	0.00136	0.00749	CcSEcCtD
Mifepristone—Hypokalaemia—Carmustine—brain cancer	0.0013	0.00715	CcSEcCtD
Mifepristone—Muscular weakness—Carmustine—brain cancer	0.00126	0.00693	CcSEcCtD
Mifepristone—Hypokalaemia—Temozolomide—brain cancer	0.00126	0.00691	CcSEcCtD
Mifepristone—Breast disorder—Temozolomide—brain cancer	0.00125	0.00686	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00124	0.00683	CcSEcCtD
Mifepristone—Haemoglobin—Hydroxyurea—brain cancer	0.00123	0.00676	CcSEcCtD
Mifepristone—Haemorrhage—Hydroxyurea—brain cancer	0.00122	0.00672	CcSEcCtD
Mifepristone—Muscular weakness—Temozolomide—brain cancer	0.00122	0.00669	CcSEcCtD
Mifepristone—Hypertension—Procarbazine—brain cancer	0.00119	0.00653	CcSEcCtD
Mifepristone—Myalgia—Procarbazine—brain cancer	0.00117	0.00644	CcSEcCtD
Mifepristone—Arthralgia—Procarbazine—brain cancer	0.00117	0.00644	CcSEcCtD
Mifepristone—Anxiety—Procarbazine—brain cancer	0.00117	0.00641	CcSEcCtD
Mifepristone—Dry mouth—Procarbazine—brain cancer	0.00115	0.00629	CcSEcCtD
Mifepristone—Vomiting—Lomustine—brain cancer	0.00113	0.00618	CcSEcCtD
Mifepristone—Oedema—Procarbazine—brain cancer	0.00112	0.00617	CcSEcCtD
Mifepristone—Infection—Procarbazine—brain cancer	0.00112	0.00613	CcSEcCtD
Mifepristone—Angiopathy—Hydroxyurea—brain cancer	0.00111	0.0061	CcSEcCtD
Mifepristone—Chills—Hydroxyurea—brain cancer	0.0011	0.00603	CcSEcCtD
Mifepristone—Anorexia—Procarbazine—brain cancer	0.00107	0.00588	CcSEcCtD
Mifepristone—Infestation NOS—Temozolomide—brain cancer	0.00107	0.00585	CcSEcCtD
Mifepristone—Infestation—Temozolomide—brain cancer	0.00107	0.00585	CcSEcCtD
Mifepristone—Nausea—Lomustine—brain cancer	0.00105	0.00577	CcSEcCtD
Mifepristone—Hypotension—Procarbazine—brain cancer	0.00105	0.00577	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00102	0.00562	CcSEcCtD
Mifepristone—Insomnia—Procarbazine—brain cancer	0.00102	0.00558	CcSEcCtD
Mifepristone—Sinusitis—Temozolomide—brain cancer	0.000999	0.00549	CcSEcCtD
Mifepristone—Somnolence—Procarbazine—brain cancer	0.000999	0.00549	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000996	0.00547	CcSEcCtD
Mifepristone—Cramp muscle—Etoposide—brain cancer	0.000996	0.00547	CcSEcCtD
Mifepristone—Haemoglobin—Carmustine—brain cancer	0.000994	0.00546	CcSEcCtD
Mifepristone—Haemorrhage—Carmustine—brain cancer	0.000989	0.00543	CcSEcCtD
Mifepristone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000989	0.00543	CcSEcCtD
Mifepristone—Decreased appetite—Procarbazine—brain cancer	0.000977	0.00536	CcSEcCtD
Mifepristone—Oedema peripheral—Carmustine—brain cancer	0.000975	0.00535	CcSEcCtD
Mifepristone—Connective tissue disorder—Carmustine—brain cancer	0.000972	0.00534	CcSEcCtD
Mifepristone—Fatigue—Procarbazine—brain cancer	0.000969	0.00532	CcSEcCtD
Mifepristone—Haemoglobin—Temozolomide—brain cancer	0.000961	0.00528	CcSEcCtD
Mifepristone—Malaise—Hydroxyurea—brain cancer	0.000961	0.00528	CcSEcCtD
Mifepristone—Pain—Procarbazine—brain cancer	0.000961	0.00528	CcSEcCtD
Mifepristone—Constipation—Procarbazine—brain cancer	0.000961	0.00528	CcSEcCtD
Mifepristone—Haemorrhage—Temozolomide—brain cancer	0.000956	0.00525	CcSEcCtD
Mifepristone—Oedema peripheral—Temozolomide—brain cancer	0.000942	0.00517	CcSEcCtD
Mifepristone—Connective tissue disorder—Temozolomide—brain cancer	0.00094	0.00516	CcSEcCtD
Mifepristone—Feeling abnormal—Procarbazine—brain cancer	0.000926	0.00508	CcSEcCtD
Mifepristone—Gastrointestinal pain—Procarbazine—brain cancer	0.000919	0.00505	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000901	0.00495	CcSEcCtD
Mifepristone—Discomfort—Hydroxyurea—brain cancer	0.000896	0.00492	CcSEcCtD
Mifepristone—Urticaria—Procarbazine—brain cancer	0.000893	0.0049	CcSEcCtD
Mifepristone—Abdominal pain—Procarbazine—brain cancer	0.000888	0.00488	CcSEcCtD
Mifepristone—Body temperature increased—Procarbazine—brain cancer	0.000888	0.00488	CcSEcCtD
Mifepristone—Oedema—Hydroxyurea—brain cancer	0.00087	0.00478	CcSEcCtD
Mifepristone—Angiopathy—Temozolomide—brain cancer	0.000867	0.00476	CcSEcCtD
Mifepristone—Mental disorder—Carmustine—brain cancer	0.000867	0.00476	CcSEcCtD
Mifepristone—Infection—Hydroxyurea—brain cancer	0.000864	0.00474	CcSEcCtD
Mifepristone—Mediastinal disorder—Temozolomide—brain cancer	0.000862	0.00473	CcSEcCtD
Mifepristone—Malnutrition—Carmustine—brain cancer	0.000861	0.00473	CcSEcCtD
Mifepristone—Chills—Temozolomide—brain cancer	0.000858	0.00471	CcSEcCtD
Mifepristone—Nervous system disorder—Hydroxyurea—brain cancer	0.000853	0.00468	CcSEcCtD
Mifepristone—Infestation—Etoposide—brain cancer	0.000852	0.00468	CcSEcCtD
Mifepristone—Infestation NOS—Etoposide—brain cancer	0.000852	0.00468	CcSEcCtD
Mifepristone—Skin disorder—Hydroxyurea—brain cancer	0.000845	0.00464	CcSEcCtD
Mifepristone—Mental disorder—Temozolomide—brain cancer	0.000838	0.0046	CcSEcCtD
Mifepristone—NR3C1—hindbrain—brain cancer	0.000837	0.0399	CbGeAlD
Mifepristone—Back pain—Carmustine—brain cancer	0.000833	0.00458	CcSEcCtD
Mifepristone—Malnutrition—Temozolomide—brain cancer	0.000832	0.00457	CcSEcCtD
Mifepristone—Anorexia—Hydroxyurea—brain cancer	0.000829	0.00455	CcSEcCtD
Mifepristone—Hypersensitivity—Procarbazine—brain cancer	0.000828	0.00455	CcSEcCtD
Mifepristone—Asthenia—Procarbazine—brain cancer	0.000806	0.00443	CcSEcCtD
Mifepristone—Back pain—Temozolomide—brain cancer	0.000805	0.00442	CcSEcCtD
Mifepristone—Pruritus—Procarbazine—brain cancer	0.000795	0.00437	CcSEcCtD
Mifepristone—Dyspnoea—Hydroxyurea—brain cancer	0.000775	0.00426	CcSEcCtD
Mifepristone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000775	0.0107	CbGpPWpGaD
Mifepristone—Somnolence—Hydroxyurea—brain cancer	0.000773	0.00425	CcSEcCtD
Mifepristone—Ill-defined disorder—Temozolomide—brain cancer	0.000772	0.00424	CcSEcCtD
Mifepristone—CYP3A7—endocrine gland—brain cancer	0.000769	0.0367	CbGeAlD
Mifepristone—Diarrhoea—Procarbazine—brain cancer	0.000769	0.00422	CcSEcCtD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—ESR2—brain cancer	0.000768	0.0106	CbGpPWpGaD
Mifepristone—Angioedema—Temozolomide—brain cancer	0.000761	0.00418	CcSEcCtD
Mifepristone—Decreased appetite—Hydroxyurea—brain cancer	0.000756	0.00415	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000751	0.00412	CcSEcCtD
Mifepristone—Malaise—Temozolomide—brain cancer	0.000751	0.00412	CcSEcCtD
Mifepristone—Fatigue—Hydroxyurea—brain cancer	0.00075	0.00412	CcSEcCtD
Mifepristone—Hypertension—Carmustine—brain cancer	0.000744	0.00408	CcSEcCtD
Mifepristone—Constipation—Hydroxyurea—brain cancer	0.000744	0.00408	CcSEcCtD
Mifepristone—Pain—Hydroxyurea—brain cancer	0.000744	0.00408	CcSEcCtD
Mifepristone—Dizziness—Procarbazine—brain cancer	0.000743	0.00408	CcSEcCtD
Mifepristone—Myalgia—Carmustine—brain cancer	0.000733	0.00403	CcSEcCtD
Mifepristone—Anxiety—Carmustine—brain cancer	0.000731	0.00401	CcSEcCtD
Mifepristone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00072	0.0099	CbGpPWpGaD
Mifepristone—Hypertension—Temozolomide—brain cancer	0.000719	0.00395	CcSEcCtD
Mifepristone—Feeling abnormal—Hydroxyurea—brain cancer	0.000717	0.00393	CcSEcCtD
Mifepristone—Vomiting—Procarbazine—brain cancer	0.000714	0.00392	CcSEcCtD
Mifepristone—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00071	0.00977	CbGpPWpGaD
Mifepristone—Arthralgia—Temozolomide—brain cancer	0.000709	0.00389	CcSEcCtD
Mifepristone—Myalgia—Temozolomide—brain cancer	0.000709	0.00389	CcSEcCtD
Mifepristone—Rash—Procarbazine—brain cancer	0.000708	0.00389	CcSEcCtD
Mifepristone—Dermatitis—Procarbazine—brain cancer	0.000708	0.00389	CcSEcCtD
Mifepristone—Anxiety—Temozolomide—brain cancer	0.000706	0.00388	CcSEcCtD
Mifepristone—Headache—Procarbazine—brain cancer	0.000704	0.00387	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000704	0.00386	CcSEcCtD
Mifepristone—Oedema—Carmustine—brain cancer	0.000703	0.00386	CcSEcCtD
Mifepristone—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000702	0.00965	CbGpPWpGaD
Mifepristone—Discomfort—Temozolomide—brain cancer	0.0007	0.00384	CcSEcCtD
Mifepristone—Infection—Carmustine—brain cancer	0.000698	0.00383	CcSEcCtD
Mifepristone—Angiopathy—Etoposide—brain cancer	0.000694	0.00381	CcSEcCtD
Mifepristone—Dry mouth—Temozolomide—brain cancer	0.000693	0.00381	CcSEcCtD
Mifepristone—Mediastinal disorder—Etoposide—brain cancer	0.00069	0.00379	CcSEcCtD
Mifepristone—Body temperature increased—Hydroxyurea—brain cancer	0.000687	0.00377	CcSEcCtD
Mifepristone—Chills—Etoposide—brain cancer	0.000686	0.00377	CcSEcCtD
Mifepristone—Oedema—Temozolomide—brain cancer	0.000679	0.00373	CcSEcCtD
Mifepristone—NR3C1—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000677	0.00932	CbGpPWpGaD
Mifepristone—Infection—Temozolomide—brain cancer	0.000675	0.00371	CcSEcCtD
Mifepristone—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.000674	0.00927	CbGpPWpGaD
Mifepristone—NR3C1—Nuclear Receptors—ESR2—brain cancer	0.000674	0.00927	CbGpPWpGaD
Mifepristone—Anorexia—Carmustine—brain cancer	0.00067	0.00368	CcSEcCtD
Mifepristone—Nausea—Procarbazine—brain cancer	0.000667	0.00366	CcSEcCtD
Mifepristone—Nervous system disorder—Temozolomide—brain cancer	0.000666	0.00366	CcSEcCtD
Mifepristone—Skin disorder—Temozolomide—brain cancer	0.00066	0.00362	CcSEcCtD
Mifepristone—Hypotension—Carmustine—brain cancer	0.000657	0.00361	CcSEcCtD
Mifepristone—Anorexia—Temozolomide—brain cancer	0.000648	0.00356	CcSEcCtD
Mifepristone—Back pain—Etoposide—brain cancer	0.000644	0.00354	CcSEcCtD
Mifepristone—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000642	0.00883	CbGpPWpGaD
Mifepristone—Hypersensitivity—Hydroxyurea—brain cancer	0.000641	0.00352	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00064	0.00352	CcSEcCtD
Mifepristone—Muscle spasms—Etoposide—brain cancer	0.00064	0.00352	CcSEcCtD
Mifepristone—Insomnia—Carmustine—brain cancer	0.000636	0.00349	CcSEcCtD
Mifepristone—Dyspnoea—Carmustine—brain cancer	0.000627	0.00344	CcSEcCtD
Mifepristone—Somnolence—Carmustine—brain cancer	0.000625	0.00343	CcSEcCtD
Mifepristone—Asthenia—Hydroxyurea—brain cancer	0.000624	0.00343	CcSEcCtD
Mifepristone—CYP2D6—hindbrain—brain cancer	0.000623	0.0297	CbGeAlD
Mifepristone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000619	0.0034	CcSEcCtD
Mifepristone—Ill-defined disorder—Etoposide—brain cancer	0.000618	0.00339	CcSEcCtD
Mifepristone—Insomnia—Temozolomide—brain cancer	0.000614	0.00337	CcSEcCtD
Mifepristone—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000611	0.00841	CbGpPWpGaD
Mifepristone—Decreased appetite—Carmustine—brain cancer	0.000611	0.00336	CcSEcCtD
Mifepristone—PGR—Signaling by ERBB4—GFAP—brain cancer	0.000608	0.00836	CbGpPWpGaD
Mifepristone—Gastrointestinal disorder—Carmustine—brain cancer	0.000607	0.00333	CcSEcCtD
Mifepristone—Dyspnoea—Temozolomide—brain cancer	0.000606	0.00333	CcSEcCtD
Mifepristone—Somnolence—Temozolomide—brain cancer	0.000604	0.00332	CcSEcCtD
Mifepristone—Constipation—Carmustine—brain cancer	0.000601	0.0033	CcSEcCtD
Mifepristone—Pain—Carmustine—brain cancer	0.000601	0.0033	CcSEcCtD
Mifepristone—PGR—pituitary gland—brain cancer	0.000601	0.0287	CbGeAlD
Mifepristone—Malaise—Etoposide—brain cancer	0.000601	0.0033	CcSEcCtD
Mifepristone—Diarrhoea—Hydroxyurea—brain cancer	0.000595	0.00327	CcSEcCtD
Mifepristone—Decreased appetite—Temozolomide—brain cancer	0.00059	0.00324	CcSEcCtD
Mifepristone—AR—telencephalon—brain cancer	0.000588	0.028	CbGeAlD
Mifepristone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000586	0.00322	CcSEcCtD
Mifepristone—Fatigue—Temozolomide—brain cancer	0.000586	0.00322	CcSEcCtD
Mifepristone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000583	0.00803	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000582	0.008	CbGpPWpGaD
Mifepristone—Constipation—Temozolomide—brain cancer	0.000581	0.00319	CcSEcCtD
Mifepristone—Pain—Temozolomide—brain cancer	0.000581	0.00319	CcSEcCtD
Mifepristone—Feeling abnormal—Carmustine—brain cancer	0.000579	0.00318	CcSEcCtD
Mifepristone—Hypertension—Etoposide—brain cancer	0.000575	0.00316	CcSEcCtD
Mifepristone—Dizziness—Hydroxyurea—brain cancer	0.000575	0.00316	CcSEcCtD
Mifepristone—Gastrointestinal pain—Carmustine—brain cancer	0.000575	0.00316	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000563	0.00309	CcSEcCtD
Mifepristone—Discomfort—Etoposide—brain cancer	0.00056	0.00308	CcSEcCtD
Mifepristone—Feeling abnormal—Temozolomide—brain cancer	0.00056	0.00307	CcSEcCtD
Mifepristone—ABCC1—telencephalon—brain cancer	0.000558	0.0266	CbGeAlD
Mifepristone—Body temperature increased—Carmustine—brain cancer	0.000556	0.00305	CcSEcCtD
Mifepristone—Abdominal pain—Carmustine—brain cancer	0.000556	0.00305	CcSEcCtD
Mifepristone—Gastrointestinal pain—Temozolomide—brain cancer	0.000555	0.00305	CcSEcCtD
Mifepristone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000553	0.00761	CbGpPWpGaD
Mifepristone—Vomiting—Hydroxyurea—brain cancer	0.000553	0.00304	CcSEcCtD
Mifepristone—Rash—Hydroxyurea—brain cancer	0.000548	0.00301	CcSEcCtD
Mifepristone—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000548	0.00754	CbGpPWpGaD
Mifepristone—Dermatitis—Hydroxyurea—brain cancer	0.000548	0.00301	CcSEcCtD
Mifepristone—Headache—Hydroxyurea—brain cancer	0.000545	0.00299	CcSEcCtD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—brain cancer	0.000541	0.00745	CbGpPWpGaD
Mifepristone—Infection—Etoposide—brain cancer	0.00054	0.00297	CcSEcCtD
Mifepristone—Urticaria—Temozolomide—brain cancer	0.00054	0.00296	CcSEcCtD
Mifepristone—Body temperature increased—Temozolomide—brain cancer	0.000537	0.00295	CcSEcCtD
Mifepristone—Abdominal pain—Temozolomide—brain cancer	0.000537	0.00295	CcSEcCtD
Mifepristone—NR3C1—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000532	0.00732	CbGpPWpGaD
Mifepristone—Skin disorder—Etoposide—brain cancer	0.000528	0.0029	CcSEcCtD
Mifepristone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000527	0.00725	CbGpPWpGaD
Mifepristone—Anorexia—Etoposide—brain cancer	0.000518	0.00285	CcSEcCtD
Mifepristone—Hypersensitivity—Carmustine—brain cancer	0.000518	0.00284	CcSEcCtD
Mifepristone—Nausea—Hydroxyurea—brain cancer	0.000516	0.00284	CcSEcCtD
Mifepristone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000512	0.00704	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—HES5—brain cancer	0.000511	0.00704	CbGpPWpGaD
Mifepristone—Hypotension—Etoposide—brain cancer	0.000508	0.00279	CcSEcCtD
Mifepristone—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000505	0.00695	CbGpPWpGaD
Mifepristone—Asthenia—Carmustine—brain cancer	0.000504	0.00277	CcSEcCtD
Mifepristone—Hypersensitivity—Temozolomide—brain cancer	0.0005	0.00275	CcSEcCtD
Mifepristone—AR—gonad—brain cancer	0.000491	0.0234	CbGeAlD
Mifepristone—Asthenia—Temozolomide—brain cancer	0.000487	0.00268	CcSEcCtD
Mifepristone—Dyspnoea—Etoposide—brain cancer	0.000485	0.00266	CcSEcCtD
Mifepristone—Somnolence—Etoposide—brain cancer	0.000483	0.00265	CcSEcCtD
Mifepristone—Diarrhoea—Carmustine—brain cancer	0.000481	0.00264	CcSEcCtD
Mifepristone—Pruritus—Temozolomide—brain cancer	0.000481	0.00264	CcSEcCtD
Mifepristone—NR3C1—brainstem—brain cancer	0.00048	0.0229	CbGeAlD
Mifepristone—AR—pituitary gland—brain cancer	0.000479	0.0228	CbGeAlD
Mifepristone—Decreased appetite—Etoposide—brain cancer	0.000473	0.00259	CcSEcCtD
Mifepristone—ABCB1—blood vessel—brain cancer	0.00047	0.0224	CbGeAlD
Mifepristone—Gastrointestinal disorder—Etoposide—brain cancer	0.000469	0.00258	CcSEcCtD
Mifepristone—Fatigue—Etoposide—brain cancer	0.000469	0.00257	CcSEcCtD
Mifepristone—PGR—endocrine gland—brain cancer	0.000466	0.0222	CbGeAlD
Mifepristone—Dizziness—Carmustine—brain cancer	0.000465	0.00255	CcSEcCtD
Mifepristone—Constipation—Etoposide—brain cancer	0.000465	0.00255	CcSEcCtD
Mifepristone—Pain—Etoposide—brain cancer	0.000465	0.00255	CcSEcCtD
Mifepristone—Diarrhoea—Temozolomide—brain cancer	0.000465	0.00255	CcSEcCtD
Mifepristone—PGR—head—brain cancer	0.00046	0.0219	CbGeAlD
Mifepristone—ABCC1—pituitary gland—brain cancer	0.000455	0.0217	CbGeAlD
Mifepristone—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.000454	0.00625	CbGpPWpGaD
Mifepristone—Dizziness—Temozolomide—brain cancer	0.000449	0.00247	CcSEcCtD
Mifepristone—Feeling abnormal—Etoposide—brain cancer	0.000448	0.00246	CcSEcCtD
Mifepristone—Vomiting—Carmustine—brain cancer	0.000447	0.00245	CcSEcCtD
Mifepristone—Gastrointestinal pain—Etoposide—brain cancer	0.000444	0.00244	CcSEcCtD
Mifepristone—Rash—Carmustine—brain cancer	0.000443	0.00243	CcSEcCtD
Mifepristone—Dermatitis—Carmustine—brain cancer	0.000443	0.00243	CcSEcCtD
Mifepristone—Headache—Carmustine—brain cancer	0.00044	0.00242	CcSEcCtD
Mifepristone—Vomiting—Temozolomide—brain cancer	0.000432	0.00237	CcSEcCtD
Mifepristone—Urticaria—Etoposide—brain cancer	0.000432	0.00237	CcSEcCtD
Mifepristone—Body temperature increased—Etoposide—brain cancer	0.00043	0.00236	CcSEcCtD
Mifepristone—Abdominal pain—Etoposide—brain cancer	0.00043	0.00236	CcSEcCtD
Mifepristone—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000429	0.0059	CbGpPWpGaD
Mifepristone—Rash—Temozolomide—brain cancer	0.000428	0.00235	CcSEcCtD
Mifepristone—Dermatitis—Temozolomide—brain cancer	0.000428	0.00235	CcSEcCtD
Mifepristone—NR3C1—telencephalon—brain cancer	0.000426	0.0203	CbGeAlD
Mifepristone—Headache—Temozolomide—brain cancer	0.000426	0.00234	CcSEcCtD
Mifepristone—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000423	0.00582	CbGpPWpGaD
Mifepristone—PGR—central nervous system—brain cancer	0.000419	0.02	CbGeAlD
Mifepristone—Nausea—Carmustine—brain cancer	0.000418	0.00229	CcSEcCtD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000416	0.00572	CbGpPWpGaD
Mifepristone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000415	0.00571	CbGpPWpGaD
Mifepristone—AR—spinal cord—brain cancer	0.000412	0.0196	CbGeAlD
Mifepristone—PGR—cerebellum—brain cancer	0.00041	0.0195	CbGeAlD
Mifepristone—Nausea—Temozolomide—brain cancer	0.000403	0.00222	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—brain cancer	0.0004	0.0022	CcSEcCtD
Mifepristone—Asthenia—Etoposide—brain cancer	0.00039	0.00214	CcSEcCtD
Mifepristone—Pruritus—Etoposide—brain cancer	0.000385	0.00211	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—brain cancer	0.000372	0.00204	CcSEcCtD
Mifepristone—AR—endocrine gland—brain cancer	0.000371	0.0177	CbGeAlD
Mifepristone—AR—head—brain cancer	0.000366	0.0175	CbGeAlD
Mifepristone—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000362	0.00498	CbGpPWpGaD
Mifepristone—Dizziness—Etoposide—brain cancer	0.000359	0.00197	CcSEcCtD
Mifepristone—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000358	0.00492	CbGpPWpGaD
Mifepristone—CYP2D6—brainstem—brain cancer	0.000357	0.017	CbGeAlD
Mifepristone—NR3C1—gonad—brain cancer	0.000355	0.0169	CbGeAlD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00035	0.00481	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—VAV1—brain cancer	0.000347	0.00478	CbGpPWpGaD
Mifepristone—NR3C1—pituitary gland—brain cancer	0.000347	0.0165	CbGeAlD
Mifepristone—Vomiting—Etoposide—brain cancer	0.000346	0.0019	CcSEcCtD
Mifepristone—Rash—Etoposide—brain cancer	0.000343	0.00188	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—brain cancer	0.000342	0.00188	CcSEcCtD
Mifepristone—Headache—Etoposide—brain cancer	0.000341	0.00187	CcSEcCtD
Mifepristone—NR3C1—medulla oblongata—brain cancer	0.000335	0.016	CbGeAlD
Mifepristone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000335	0.0046	CbGpPWpGaD
Mifepristone—AR—central nervous system—brain cancer	0.000334	0.0159	CbGeAlD
Mifepristone—PGR—brain—brain cancer	0.000333	0.0159	CbGeAlD
Mifepristone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00033	0.00454	CbGpPWpGaD
Mifepristone—Nausea—Etoposide—brain cancer	0.000323	0.00177	CcSEcCtD
Mifepristone—CYP2D6—telencephalon—brain cancer	0.000317	0.0151	CbGeAlD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000312	0.00429	CbGpPWpGaD
Mifepristone—ABCC1—cerebellum—brain cancer	0.00031	0.0148	CbGeAlD
Mifepristone—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.00031	0.00426	CbGpPWpGaD
Mifepristone—NR3C1—midbrain—brain cancer	0.000306	0.0146	CbGeAlD
Mifepristone—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000306	0.00421	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000305	0.0042	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—brain cancer	0.000302	0.00416	CbGpPWpGaD
Mifepristone—NR3C1—spinal cord—brain cancer	0.000298	0.0142	CbGeAlD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000295	0.00406	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000289	0.00398	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000287	0.00395	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PDGFRA—brain cancer	0.000284	0.00391	CbGpPWpGaD
Mifepristone—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000284	0.00391	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000283	0.00389	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000281	0.00386	CbGpPWpGaD
Mifepristone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000271	0.00373	CbGpPWpGaD
Mifepristone—CYP3A5—endocrine gland—brain cancer	0.000271	0.0129	CbGeAlD
Mifepristone—NR3C1—endocrine gland—brain cancer	0.000269	0.0128	CbGeAlD
Mifepristone—AR—brain—brain cancer	0.000265	0.0127	CbGeAlD
Mifepristone—NR3C1—head—brain cancer	0.000265	0.0126	CbGeAlD
Mifepristone—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000254	0.0035	CbGpPWpGaD
Mifepristone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000252	0.00347	CbGpPWpGaD
Mifepristone—ABCC1—brain—brain cancer	0.000252	0.012	CbGeAlD
Mifepristone—PGR—Signaling by ERBB4—IRS2—brain cancer	0.00025	0.00343	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000244	0.00336	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—APC—brain cancer	0.000242	0.00334	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	0.000242	0.00333	CbGpPWpGaD
Mifepristone—NR3C1—central nervous system—brain cancer	0.000242	0.0115	CbGeAlD
Mifepristone—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000242	0.00333	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000239	0.00329	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000237	0.00326	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000237	0.00326	CbGpPWpGaD
Mifepristone—NR3C1—cerebellum—brain cancer	0.000237	0.0113	CbGeAlD
Mifepristone—ABCB1—telencephalon—brain cancer	0.000228	0.0109	CbGeAlD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000228	0.00314	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000224	0.00308	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000223	0.00307	CbGpPWpGaD
Mifepristone—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.00022	0.00303	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000218	0.003	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000218	0.00299	CbGpPWpGaD
Mifepristone—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000217	0.00299	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000217	0.00298	CbGpPWpGaD
Mifepristone—CYP3A4—endocrine gland—brain cancer	0.000203	0.00969	CbGeAlD
Mifepristone—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000201	0.00277	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.0002	0.00276	CbGpPWpGaD
Mifepristone—CYP2D6—endocrine gland—brain cancer	0.0002	0.00953	CbGeAlD
Mifepristone—CYP2D6—head—brain cancer	0.000197	0.00941	CbGeAlD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000197	0.0027	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000194	0.00267	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000193	0.00265	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CDKN2A—brain cancer	0.000192	0.00265	CbGpPWpGaD
Mifepristone—NR3C1—brain—brain cancer	0.000192	0.00916	CbGeAlD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000191	0.00262	CbGpPWpGaD
Mifepristone—ABCB1—gonad—brain cancer	0.00019	0.00907	CbGeAlD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000189	0.0026	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—OR14C36—brain cancer	0.000188	0.00258	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—OR4C12—brain cancer	0.000188	0.00258	CbGpPWpGaD
Mifepristone—ABCB1—pituitary gland—brain cancer	0.000186	0.00885	CbGeAlD
Mifepristone—CYP3A4—central nervous system—brain cancer	0.000183	0.00873	CbGeAlD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00018	0.00248	CbGpPWpGaD
Mifepristone—CYP2D6—central nervous system—brain cancer	0.00018	0.00859	CbGeAlD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000179	0.00247	CbGpPWpGaD
Mifepristone—ABCB1—medulla oblongata—brain cancer	0.000179	0.00854	CbGeAlD
Mifepristone—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.000177	0.00243	CbGpPWpGaD
Mifepristone—CYP2D6—cerebellum—brain cancer	0.000176	0.0084	CbGeAlD
Mifepristone—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000175	0.00241	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000172	0.00237	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—ERBB2—brain cancer	0.000171	0.00235	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—HES1—brain cancer	0.000169	0.00233	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—IL2—brain cancer	0.000167	0.00229	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—CTNNB1—brain cancer	0.000165	0.00227	CbGpPWpGaD
Mifepristone—ABCB1—midbrain—brain cancer	0.000164	0.00781	CbGeAlD
Mifepristone—NR3C1—Adipogenesis—IRS2—brain cancer	0.000163	0.00225	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—RELA—brain cancer	0.000163	0.00224	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCND1—brain cancer	0.000163	0.00224	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CTNNB1—brain cancer	0.000161	0.00221	CbGpPWpGaD
Mifepristone—ABCB1—spinal cord—brain cancer	0.00016	0.00762	CbGeAlD
Mifepristone—PGR—Signaling Pathways—DTX2—brain cancer	0.000159	0.00219	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—ESR2—brain cancer	0.000159	0.00219	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000154	0.00212	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000153	0.0021	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.000153	0.0021	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000151	0.00207	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000149	0.00205	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000149	0.00204	CbGpPWpGaD
Mifepristone—ABCC1—Disease—DTX2—brain cancer	0.000149	0.00204	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—IL2—brain cancer	0.000147	0.00202	CbGpPWpGaD
Mifepristone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000144	0.00198	CbGpPWpGaD
Mifepristone—ABCB1—endocrine gland—brain cancer	0.000144	0.00686	CbGeAlD
Mifepristone—CYP2D6—brain—brain cancer	0.000143	0.00682	CbGeAlD
Mifepristone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000142	0.00195	CbGpPWpGaD
Mifepristone—ABCB1—head—brain cancer	0.000142	0.00677	CbGeAlD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.00014	0.00192	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000139	0.00191	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000138	0.0019	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—MYC—brain cancer	0.00013	0.00179	CbGpPWpGaD
Mifepristone—ABCB1—central nervous system—brain cancer	0.00013	0.00618	CbGeAlD
Mifepristone—ABCB1—cerebellum—brain cancer	0.000127	0.00604	CbGeAlD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000124	0.00171	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000121	0.00167	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTCH2—brain cancer	0.000121	0.00166	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—EGFR—brain cancer	0.000119	0.00163	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000118	0.00162	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HES5—brain cancer	0.000117	0.00161	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.000116	0.0016	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000116	0.00159	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NOTCH2—brain cancer	0.000115	0.00158	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000115	0.00158	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STRADA—brain cancer	0.000114	0.00156	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000112	0.00154	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HES5—brain cancer	0.000109	0.0015	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000109	0.00149	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—brain cancer	0.000107	0.00147	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000103	0.00142	CbGpPWpGaD
Mifepristone—ABCB1—brain—brain cancer	0.000103	0.00491	CbGeAlD
Mifepristone—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000101	0.00139	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.0001	0.00138	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	9.95e-05	0.00137	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	9.84e-05	0.00135	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—CTNNB1—brain cancer	9.81e-05	0.00135	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.6e-05	0.00132	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.5e-05	0.00131	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ABR—brain cancer	9.48e-05	0.0013	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—brain cancer	9.43e-05	0.0013	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	9.32e-05	0.00128	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	9.29e-05	0.00128	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—ESR2—brain cancer	9.2e-05	0.00127	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GLI2—brain cancer	9.16e-05	0.00126	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	9.09e-05	0.00125	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NOTCH2—brain cancer	8.71e-05	0.0012	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GLI1—brain cancer	8.61e-05	0.00118	CbGpPWpGaD
Mifepristone—NR3C1—Adipogenesis—STAT3—brain cancer	8.55e-05	0.00118	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—DNMT1—brain cancer	8.53e-05	0.00117	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.48e-05	0.00117	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP2C9—brain cancer	8.41e-05	0.00116	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.37e-05	0.00115	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	8.17e-05	0.00112	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SUFU—brain cancer	8.16e-05	0.00112	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—IL2—brain cancer	8.13e-05	0.00112	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.01e-05	0.0011	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	7.98e-05	0.0011	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.91e-05	0.00109	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GFAP—brain cancer	7.87e-05	0.00108	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.7e-05	0.00106	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ESR2—brain cancer	7.66e-05	0.00105	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	7.63e-05	0.00105	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.53e-05	0.00104	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HEY1—brain cancer	7.46e-05	0.00103	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.46e-05	0.00103	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	7.35e-05	0.00101	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IDH1—brain cancer	7.34e-05	0.00101	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP2C9—brain cancer	7.33e-05	0.00101	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DLL1—brain cancer	7.32e-05	0.00101	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NOTCH2—brain cancer	7.26e-05	0.000998	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—BSG—brain cancer	7.15e-05	0.000983	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7.01e-05	0.000964	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HEY1—brain cancer	6.96e-05	0.000957	CbGpPWpGaD
Mifepristone—ABCB1—Allograft Rejection—VEGFA—brain cancer	6.91e-05	0.000951	CbGpPWpGaD
Mifepristone—ABCC1—Disease—DLL1—brain cancer	6.82e-05	0.000939	CbGpPWpGaD
Mifepristone—AR—Gene Expression—DNMT1—brain cancer	6.5e-05	0.000894	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.32e-05	0.00087	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—BSG—brain cancer	6.23e-05	0.000858	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SHH—brain cancer	6.22e-05	0.000856	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—SIRT1—brain cancer	6.17e-05	0.000849	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—IDH1—brain cancer	6.15e-05	0.000846	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.06e-05	0.000833	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TRPC6—brain cancer	6e-05	0.000826	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SMO—brain cancer	5.9e-05	0.000812	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTCH1—brain cancer	5.9e-05	0.000812	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ESR2—brain cancer	5.84e-05	0.000803	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ENO2—brain cancer	5.8e-05	0.000798	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SHH—brain cancer	5.8e-05	0.000798	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.7e-05	0.000784	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH2—brain cancer	5.53e-05	0.00076	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—IDH1—brain cancer	5.36e-05	0.000738	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2C9—brain cancer	5.3e-05	0.000729	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—brain cancer	5.02e-05	0.000691	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5e-05	0.000689	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—DNMT1—brain cancer	4.93e-05	0.000679	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ENO2—brain cancer	4.86e-05	0.000668	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.76e-05	0.000655	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH2—brain cancer	4.72e-05	0.000649	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SIRT1—brain cancer	4.7e-05	0.000647	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—BSG—brain cancer	4.51e-05	0.00062	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VAV1—brain cancer	4.5e-05	0.000619	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR2—brain cancer	4.43e-05	0.000609	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.43e-05	0.000609	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ENO2—brain cancer	4.24e-05	0.000583	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH2—brain cancer	4.19e-05	0.000577	CbGpPWpGaD
Mifepristone—ABCC1—Disease—VAV1—brain cancer	4.19e-05	0.000577	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2C9—brain cancer	4e-05	0.00055	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.91e-05	0.000538	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—IDH1—brain cancer	3.88e-05	0.000533	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.87e-05	0.000533	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HES1—brain cancer	3.87e-05	0.000532	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—brain cancer	3.82e-05	0.000526	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2C9—brain cancer	3.77e-05	0.000518	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PDGFRA—brain cancer	3.68e-05	0.000507	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HES1—brain cancer	3.61e-05	0.000496	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SPP1—brain cancer	3.57e-05	0.000492	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SIRT1—brain cancer	3.57e-05	0.000491	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PDGFRA—brain cancer	3.43e-05	0.000472	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.41e-05	0.000469	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BSG—brain cancer	3.4e-05	0.000468	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IRS2—brain cancer	3.23e-05	0.000445	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BSG—brain cancer	3.2e-05	0.000441	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.14e-05	0.000432	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.07e-05	0.000422	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ENO2—brain cancer	3.06e-05	0.000421	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IRS2—brain cancer	3.01e-05	0.000415	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—IDH1—brain cancer	2.92e-05	0.000402	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—brain cancer	2.9e-05	0.000399	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—APC—brain cancer	2.86e-05	0.000393	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CG—brain cancer	2.86e-05	0.000393	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—IDH1—brain cancer	2.76e-05	0.000379	CbGpPWpGaD
Mifepristone—ABCC1—Disease—APC—brain cancer	2.66e-05	0.000366	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.58e-05	0.000354	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2C9—brain cancer	2.46e-05	0.000339	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—brain cancer	2.42e-05	0.000332	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO2—brain cancer	2.31e-05	0.000318	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—RELA—brain cancer	2.23e-05	0.000307	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—brain cancer	2.23e-05	0.000307	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—brain cancer	2.22e-05	0.000305	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO2—brain cancer	2.18e-05	0.0003	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BSG—brain cancer	2.1e-05	0.000288	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—brain cancer	2.07e-05	0.000284	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—brain cancer	2.01e-05	0.000276	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—brain cancer	1.96e-05	0.000269	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—brain cancer	1.94e-05	0.000267	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CTNNB1—brain cancer	1.94e-05	0.000267	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—brain cancer	1.84e-05	0.000253	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CTNNB1—brain cancer	1.81e-05	0.000249	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IDH1—brain cancer	1.8e-05	0.000248	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—brain cancer	1.71e-05	0.000235	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—brain cancer	1.69e-05	0.000233	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—brain cancer	1.58e-05	0.000217	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—brain cancer	1.57e-05	0.000216	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—brain cancer	1.54e-05	0.000211	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—brain cancer	1.46e-05	0.000201	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—brain cancer	1.43e-05	0.000197	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO2—brain cancer	1.42e-05	0.000196	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—brain cancer	1.41e-05	0.000193	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—brain cancer	1.4e-05	0.000192	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—brain cancer	1.29e-05	0.000178	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—brain cancer	1.06e-05	0.000146	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—brain cancer	9.99e-06	0.000137	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—brain cancer	6.53e-06	8.99e-05	CbGpPWpGaD
